Bayesian Capital Management’s The Meet Group, Inc. Common Stock MEET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-17,660
Closed -$104K 904
2020
Q1
$104K Buy
+17,660
New +$101K 0.02% 671
2019
Q1
Sell
-25,000
Closed -$116K 865
2018
Q4
$116K Buy
25,000
+14,000
+127% +$59.7K 0.02% 547
2018
Q3
$54K Buy
+11,000
New +$49.3K 0.01% 602
2017
Q2
Sell
-39,100
Closed -$230K 681
2017
Q1
$230K Buy
39,100
+3,500
+10% +$17.8K 0.11% 317
2016
Q4
$176K Buy
35,600
+12,100
+51% +$62.5K 0.04% 539
2016
Q3
$146K Buy
+23,500
New +$144K 0.1% 310

Other funds holding MEET

Bayesian Capital Management's MEET Position: Q2 2020 in Review

Bayesian Capital Management sold out of The Meet Group, Inc. Common Stock (MEET) in Q2 2020, closing a stake of 17,660 shares — an estimated $104K sold.

Bayesian Capital Management first reported a position in MEET in Q3 2016 and held it in 6 quarters. The position peaked at $230K in Q1 2017. 131 funds tracked by Wall St. Rank hold MEET as of Q2 2020.

  • Bayesian Capital Management reported no remaining The Meet Group, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Bayesian Capital Management sold 17,660 The Meet Group, Inc. Common Stock shares in Q2 2020, an estimated $104K.
  • Bayesian Capital Management first reported a position in The Meet Group, Inc. Common Stock in Q3 2016 and held it in 6 quarters.
  • Bayesian Capital Management's The Meet Group, Inc. Common Stock position peaked at $230K in Q1 2017.
  • 131 funds tracked by Wall St. Rank held The Meet Group, Inc. Common Stock as of Q2 2020.

Based on Bayesian Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.